Effectively managing microbial contamination in pharmaceutical manufacturing demands a multi-layered approach to microbial identification. This application note presents a case study on Staphylococcus epidermidis contamination in a sterile pharmaceutical production facility, showcasing how Biolog Lab Services’ multiomic approach—integrating genomic, proteomic, and phenomic methods—provided a comprehensive microbial profile.
Multiomic Identification: Comprehensive Microbial Profiling for Pharmaceutical Contamination Control
Abstract
Effectively managing microbial contamination in pharmaceutical manufacturing demands a multi-layered approach to microbial identification. This application note presents a case study on Staphylococcus epidermidis contamination in a sterile pharmaceutical production facility, showcasing how Biolog Lab Services’ multiomic approach—integrating genomic, proteomic, and phenomic methods—provided a comprehensive microbial profile. By utilizing Sanger Sequencing, Bruker MALDI-TOF, and phenotypic identification with the Odin™ platform, Biolog enabled the facility to develop a targeted contamination control protocol, significantly reducing biofilm persistence and contamination through precise species identification and tailored strategies.
Introduction to Multiomic Identification
Microbial contamination in pharmaceutical manufacturing is a critical challenge, particularly when dealing with resilient organisms like Staphylococcus epidermidis. A multiomic approach combining genomic, proteomic, and phenomic insights allows for a detailed microbial profile, revealing crucial aspects of microbial identity, resilience, and adaptability. Each layer of analysis contributes unique information for a holistic contamination control strategy:
- Genomics: Provides precise microbial species identification and confirmation.
- Proteomics: Offers protein profile-based identification for rapid species confirmation.
- Phenomics: Delivers metabolic adaptability and environmental response insights.
Using S. epidermidis as a case study, this application note demonstrates how Biolog’s multiomic tools enabled a comprehensive, targeted approach to contamination control in a sterile pharmaceutical manufacturing environment.
Genomic Analysis with Sanger Sequencing
Sanger Sequencing serves as the foundation for identifying microbial species by targeting specific genetic markers, such as the 16S rRNA gene in bacteria. In this case, genomic analysis was essential for determining the likely presence of S. epidermidis, differentiating it from other staphylococcal species with similar biofilm-forming potential. Sanger Sequencing provided the initial identification, establishing a reliable baseline for further analysis.
Significance of Genomic Data
Genomic identification provided the first identification of S. epidermidis and provided insights into its genetic potential for biofilm formation and persistence. This foundational layer guided the facility’s contamination control strategy, highlighting the need for tailored cleaning protocols beyond standard practices.
Case Analysis
With 16S rRNA sequencing, S. epidermidis was identified as the primary contaminant, prompting a biofilm-targeted approach. This genomic foundation supported the decision to proceed with proteomics to confirm the species-level call and phenomic analyses to optimize cleaning strategies.
| Sample ID: C2501170917-Staphylococcus epidermis | |||
|---|---|---|---|
| Top 10 Matches | |||
| Match | %Diff | Length | Library Entry Name |
| 1 | 0.19 | 535 | Staphylococcus-epidermidis |
| 2 | 0.93 | 535 | Staphylococcus-caprae |
| 3 | 1.12 | 535 | Staphylococcus-capitis |
| 4 | 2.43 | 535 | Staphylococcus-muscae |
| 5 | 2.43 | 535 | Staphylococcus-warneri |
| 6 | 2.43 | 535 | Staphylococcus-aureus-aureus |
| 7 | 2.61 | 535 | Staphylococcus-pasteuri |
| 8 | 2.80 | 535 | Staphylococcus-haemolyticus |
| 9 | 2.89 | 535 | Staphylococcus-hominis-hominis |
| 10 | 3.26 | 535 | Staphylococcus-lugdunensis |
| Closest Match: Staphylococcus-epidermidis Confidence Level: Species Closely Related | |||
Figure 1: 16S DNA Gene Analysis for Staphylococcus epidermidis. Genetic relationships are expressed in the form of Percent Genetic Differences (%Diff). This is calculated as the percentage of positions that differ when two sequences are aligned in a way to minimize sequence gaps.
Figure 2: 16S DNA Gene Analysis for Staphylococcus epidermidis. Neighbor joining tree displays the inter-species relationships between the top ten matches and the unknown.
Proteomic Identification with Bruker MALDI-TOF
The Bruker MALDI-TOF mass spectrometry system provides a rapid and accurate means for microbial species identification based on protein profiles. MALDI-TOF uses mass-to-charge ratios of proteins to generate a unique “fingerprint” for each species, allowing precise identification. In this case, MALDI-TOF confirmed S. epidermidis as the contaminant by matching its protein fingerprint against a comprehensive reference database.
Importance of Proteomic Identification
MALDI-TOF’s rapid identification capabilities are invaluable in pharmaceutical contamination control. Traditional methods may require days for confirmation, while MALDI-TOF enables labs to provide next-day identification, for swift implementation of specifically tailored contamination control measures. This proteomic data helped to confirm the identity of the contaminating species, enabling a rapid response.
Case Analysis
The speed and accuracy of MALDI-TOF proteomic identification allowed facility managers to confirm S. epidermidis and initiate tailored interventions. This rapid confirmation reinforced contamination control measures, resulting in an overall reduction of biofilm persistence.
Figure 3: MALDI-TOF Spectrum for Staphylococcus epidermidis. The spectral profile provides a unique identifier for S. epidermidis, facilitating rapid and precise contamination management.
Figure 4: MALDI-TOF Spectrum for Staphylococcus epidermidis. Score value is calculated by a matching algorithm used to compare protein spectral patterns.
Phenomic Analysis with Odin
The Odin phenotypic identification platform captures S. epidermidis’s phenomic fingerprint using Biolog’s GEN III plate, which reports the metabolic activity of aerobic bacteria under 95 pre-selected conditions in a single microplate. In this way, we can quantify the utilization of 71 carbon sources and sensitivity to 21 stress conditions to generate a unique phenotypic profile. This phenotypic profile can then be used as a fingerprint to identify the organism and provide useful phenotypic data critical for managing contamination in pharmaceutical manufacturing facilities. The GEN III plate ID profile revealed that S. epidermidis growth is significantly increased on only a few carbon sources: maltose (A3), α-D-lactose (B2), α-D-glucose (C1), D-fructose (C3), D-fructose-6-phosphate (D7), pectin (F1), and methyl pyruvate (G2). This information underscores the importance of limiting these carbon sources on production surfaces and in cleaning materials to reduce the risk of microbial colonization. Additionally, columns 10–12 of the GEN III plate provide actionable information on the sensitivity of a species to various inhibitors. For example, the contaminant strain was more susceptible to acidic pH (A12) compared to more neutral pH conditions (A11) and exhibited halotolerance (B10–12), informing decisions on sensitivity-targeted cleaning protocols and environmental adjustments to minimize contamination risks. While antibiotics are not directly used in industrial decontamination, the GEN III plate also provides data on resistance to common antibiotics. Here, we found that the S. epidermidis isolate was susceptible to macrolide (D10), rifamycin SV (D11), minocycline (D12), lincomycin (E10), guanidine HCl (E11), Niaproof 4 (E12), and vancomycin (F10).
Impact of Phenomic Data
Odin’s phenotypic insights provided useful information on S. epidermidis’s metabolic resilience as well as data on stress resistance. These factors can inform decisions on tailored contamination management strategies in pharmaceutical manufacturing through targeted pH and environmental controls. Additionally, having a greater understanding of the metabolic preferences of newly identified isolates can significantly decrease time and effort spent on culture condition optimization, ultimately enhancing facility cleanliness and operational efficiency.
Figure 5. Phenotypic Profile of Staphylococcus epidermidis. A heatmap detailing nutrient utilization and adaptability, informing both nutrient- and sensitivity-targeting strategies for contamination control. OD590 indicates metabolic activity through dye reduction.
Integrated Multiomic Strategy for Contamination Control
Biolog’s multiomic approach provided the facility with a complete contamination control strategy by combining:
- Genomic Data: S. epidermidis’s species identity and biofilm potential.
- Proteomic Analysis: Enabled rapid species confirmation for timely contamination response.
- Phenomic Insights: Identified metabolic traits and guided nutrient-targeted cleaning regimens.
The integration of these layers resulted in a comprehensive strategy that reduced biofilm persistence significantly within six months, supporting operational efficiency and minimizing contamination risks.
Figure 6: Integrated Multiomic Profile Summary for Staphylococcus epidermidis. Summarizes genomic, proteomic, and phenomic data, providing a holistic contamination control strategy tailored to S. epidermidis.
Conclusion
This case study of Staphylococcus epidermidis contamination exemplifies the effectiveness of Biolog’s multiomic identification in microbial management. By integrating genomic, proteomic, and phenomic insights, Biolog delivered a tailored contamination control solution that significantly reduced biofilm persistence and contamination risks in a pharmaceutical manufacturing facility.
Beyond contamination control, multiomic profiling offers value in:
- Water Quality Management: Multiomics identifies biofilm-forming species and informs water treatment protocols.
- Bioremediation: Phenomic and proteomic data guide the selection of organisms for pollutant degradation, aiding environmental sustainability.
- Quality Assurance in Food and Pharmaceuticals: Multiomics ensures rapid microbial identification, helping prevent contamination in sensitive production environments.
Multiomic profiling sets a new standard in microbial management, equipping industries with tools for precise, actionable contamination control.
